Masimo Corp $ 250.73 4.62 (1.88%)
Warning! GuruFocus has detected 1 Severe warning sign with MASI. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for MASI (Masimo Corp) from 2007 to Feb 28 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Masimo stock (MASI) PE ratio as of Feb 28 2021 is 60.56. More Details
Masimo PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Masimo PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NYSE:STE NAS:HOLX NYSE:COO NYSE:WST NYSE:VAR NYSE:TFX NAS:XRAY NAS:RGEN NYSE:HRC NAS:NVCR NYSE:BDX NAS:ISRG XPAR:EL NYSE:BAX OCSE:COLO B TSE:7741 XSWX:ALC TSE:4543 XPAR:DIM NYSE:RMD
Address 52 Discovery, Irvine, CA, USA, 92618
Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (68% of 2019 sales), followed by Europe, the Middle East, and Africa (20%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).